Effect of a Low-protein Diet Supplemented with Ketoacids on Skeletal Muscle Atrophy and Autophagy in Rats with Type 2 Diabetic Nephropathy

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Dec 5

PMID 24303049

Citations 10

Authors

Juan Huang

Jialin Wang

Lijie Gu

JinFang Bao

Jun Yin

Zhihuan Tang

Ling Wang

Weijie Yuan

Affiliations

Soon will be listed here.

Abstract

A low-protein diet supplemented with ketoacids maintains nutritional status in patients with diabetic nephropathy. The activation of autophagy has been shown in the skeletal muscle of diabetic and uremic rats. This study aimed to determine whether a low-protein diet supplemented with ketoacids improves muscle atrophy and decreases the increased autophagy observed in rats with type 2 diabetic nephropathy. In this study, 24-week-old Goto-Kakizaki male rats were randomly divided into groups that received either a normal protein diet (NPD group), a low-protein diet (LPD group) or a low-protein diet supplemented with ketoacids (LPD+KA group) for 24 weeks. Age- and weight-matched Wistar rats served as control animals and received a normal protein diet (control group). We found that protein restriction attenuated proteinuria and decreased blood urea nitrogen and serum creatinine levels. Compared with the NPD and LPD groups, the LPD+KA group showed a delay in body weight loss, an attenuation in soleus muscle mass loss and a decrease of the mean cross-sectional area of soleus muscle fibers. The mRNA and protein expression of autophagy-related genes, such as Beclin-1, LC3B, Bnip3, p62 and Cathepsin L, were increased in the soleus muscle of GK rats fed with NPD compared to Wistar rats. Importantly, LPD resulted in a slight reduction in the expression of autophagy-related genes; however, these differences were not statistically significant. In addition, LPD+KA abolished the upregulation of autophagy-related gene expression. Furthermore, the activation of autophagy in the NPD and LPD groups was confirmed by the appearance of autophagosomes or autolysosomes using electron microscopy, when compared with the Control and LPD+KA groups. Our results showed that LPD+KA abolished the activation of autophagy in skeletal muscle and decreased muscle loss in rats with type 2 diabetic nephropathy.

Citing Articles

Low protein diet supplemented with ketoacids on muscle wasting in chronic kidney disease: A clinical trial.

Zhang Y, Gu L, Wang L, Rong S, Yuan W Front Med (Lausanne). 2022; 9:949108.

PMID: 36186800 PMC: 9516635. DOI: 10.3389/fmed.2022.949108.

Low Protein Diets and Plant-Based Low Protein Diets: Do They Meet Protein Requirements of Patients with Chronic Kidney Disease?.

Verzola D, Picciotto D, Saio M, Aimasso F, Bruzzone F, Sukkar S Nutrients. 2021; 13(1).

PMID: 33383799 PMC: 7824653. DOI: 10.3390/nu13010083.

Usefulness of Urinary Creatinine/Urea Nitrogen Ratio as Indicator of Body Protein Catabolism in Dogs Fed Low Protein Diets.

Yamamoto S, Ohta Y, Hasegawa E, Hashida S, Kaneko Y, Mizutani S Front Vet Sci. 2020; 6:449.

PMID: 31921910 PMC: 6914702. DOI: 10.3389/fvets.2019.00449.

Dietary supplementation with ketoacids protects against CKD-induced oxidative damage and mitochondrial dysfunction in skeletal muscle of 5/6 nephrectomised rats.

Wang D, Wei L, Yang Y, Liu H Skelet Muscle. 2018; 8(1):18.

PMID: 29855350 PMC: 5984473. DOI: 10.1186/s13395-018-0164-z.

Effects of Low-Protein, and Supplemented Very Low-Protein Diets, on Muscle Protein Turnover in Patients With CKD.

Garibotto G, Sofia A, Parodi E, Ansaldo F, Bonanni A, Picciotto D Kidney Int Rep. 2018; 3(3):701-710.

PMID: 29854979 PMC: 5976852. DOI: 10.1016/j.ekir.2018.01.003.

References

Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S . Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008; 8(5):425-36. DOI: 10.1016/j.cmet.2008.09.002. View

Kalantar-Zadeh K, Cano N, Budde K, Chazot C, Kovesdy C, Mak R . Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol. 2011; 7(7):369-84. PMC: 3876473. DOI: 10.1038/nrneph.2011.60. View

Walser M . Ketoacids in the treatment of uremia. Clin Nephrol. 1975; 3(5):180-6. View

Carmignac V, Svensson M, Korner Z, Elowsson L, Matsumura C, Gawlik K . Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A. Hum Mol Genet. 2011; 20(24):4891-902. DOI: 10.1093/hmg/ddr427. View

Pupim L, Flakoll P, Majchrzak K, Guy D, Stenvinkel P, Ikizler T . Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int. 2005; 68(4):1857-65. DOI: 10.1111/j.1523-1755.2005.00605.x. View

Robertson L, Waugh N, Robertson A . Protein restriction for diabetic renal disease. Cochrane Database Syst Rev. 2007; (4):CD002181. PMC: 8984680. DOI: 10.1002/14651858.CD002181.pub2. View

Pupim L, Heimburger O, Qureshi A, Ikizler T, Stenvinkel P . Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int. 2005; 68(5):2368-74. DOI: 10.1111/j.1523-1755.2005.00699.x. View

Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T . LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000; 19(21):5720-8. PMC: 305793. DOI: 10.1093/emboj/19.21.5720. View

Zatz R, Meyer T, Rennke H, Brenner B . Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A. 1985; 82(17):5963-7. PMC: 390674. DOI: 10.1073/pnas.82.17.5963. View

10.

Diaz M, Kleinknecht C, Broyer M . Growth in experimental renal failure: role of calorie and amino acid intake. Kidney Int. 1975; 8(6):349-54. DOI: 10.1038/ki.1975.126. View

11.

Post Hansen H, Jensen B, Parving H . Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002; 62(1):220-8. DOI: 10.1046/j.1523-1755.2002.00421.x. View

12.

Gros F, Arnold J, Page N, Decossas M, Korganow A, Martin T . Macroautophagy is deregulated in murine and human lupus T lymphocytes. Autophagy. 2012; 8(7):1113-23. PMC: 3429547. DOI: 10.4161/auto.20275. View

13.

Sugawara T, Ito Y, Nishizawa N, Nagasawa T . Regulation of muscle protein degradation, not synthesis, by dietary leucine in rats fed a protein-deficient diet. Amino Acids. 2008; 37(4):609-16. DOI: 10.1007/s00726-008-0180-0. View

14.

Chauveau P, Barthe N, Rigalleau V, Ozenne S, Castaing F, Delclaux C . Outcome of nutritional status and body composition of uremic patients on a very low protein diet. Am J Kidney Dis. 1999; 34(3):500-7. DOI: 10.1016/s0272-6386(99)70078-8. View

15.

Aparicio M, Bellizzi V, Chauveau P, Cupisti A, Ecder T, Fouque D . Protein-restricted diets plus keto/amino acids--a valid therapeutic approach for chronic kidney disease patients. J Ren Nutr. 2012; 22(2 Suppl):S1-21. DOI: 10.1053/j.jrn.2011.09.005. View

16.

de Mutsert R, Grootendorst D, Axelsson J, Boeschoten E, Krediet R, Dekker F . Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients. Nephrol Dial Transplant. 2008; 23(9):2957-64. DOI: 10.1093/ndt/gfn167. View

17.

Noori N, Kopple J, Kovesdy C, Feroze U, Sim J, Murali S . Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2010; 5(12):2258-68. PMC: 2994088. DOI: 10.2215/CJN.02080310. View

18.

Yamamoto D, Maki T, Herningtyas E, Ikeshita N, Shibahara H, Sugiyama Y . Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats. Muscle Nerve. 2010; 41(6):819-27. DOI: 10.1002/mus.21621. View

19.

Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, GIOVANNETTI S . Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol. 1988; 29(6):280-7. View

20.

Aparicio M . Protein intake and chronic kidney disease: literature review, 2003 to 2008. J Ren Nutr. 2009; 19(5 Suppl):S5-8. DOI: 10.1053/j.jrn.2009.06.017. View